August 2026
The ovarian cancer drugs market reached USD 4.09 billion in 2025, with prominent companies such as AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (GSK) (UK), AbbVie Inc. (USA), Merck & Co., Inc. (USA) leading the ovarian cancer drugs market.
August 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
March 2026
The global kidney cancer drugs market size is calculated at USD 7.24 billion in 2025 and is projected to hit around USD 12.16 billion by 2035 with a CAGR of 5.32%.
August 2026
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
August 2026
The global AI in cancer immunotherapy drugs market size was evaluated at USD 2.80 billion in 2025 and is predicted to hit around USD 27.79 billion by 2035, growing at a CAGR of 25.80%.
December 2025
The global cancer supportive care drugs market size is projected to hit around USD 27.45 billion by 2035 from USD 22.31 billion in 2025 with a CAGR of 2.09%.
August 2025
The global injectable cytotoxic drugs market size is estimated to hit around USD 35.71 billion by 2034 increasing from USD 19.48 billion in 2024, with a CAGR of 6.25%.
August 2026
The contraceptive drugs market size reached USD 20.12 billion in 2026, with leading contraceptive drugs market companies including Pfizer Inc., Bayer AG, Merck and Co. Inc.
August 2026
The amylin analog drugs market size stood at USD 3.20 billion in 2025, with major Eli Lilly and Company, Sanofi S.A., Boehringer Ingelheim, Novartis AG. companies including amylin analog drugs market.
August 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
August 2026
The genitourinary drugs market size was USD 30.37 billion in 2026, with leading genitourinary drugs market players including Pfizer inc, johnson & johnson, bayer ag, Sanofi.
August 2026
The pulmonary alveolar proteinosis (PAP) drugs market reached USD 859.05Â million in 2026, with key pulmonary alveolar proteinosis (PAP) drugs market companies including Savara, Inc., Partner Therapeutics, Inc., Nobelpharma Co., Ltd. Amgen Inc
August 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
August 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
August 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
August 2026
The global cancer registry software market size is expected to increase from USD 94.68 million in 2025 to hit around USD 301.40 million by 2035, with a CAGR of 12.28%.
August 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
August 2026
The global breast cancer market size was estimated at USD 26.23 billion in 2025 and is projected to hit around USD 40.11 billion by 2035 with a CAGR of 4.34%.
August 2026
The cancer biopsy market size is estimated at USD 36.55 billion in 2025 and is expected to hit around USD 196.68 billion by 2035, growing at a CAGR of 18.33%.
August 2026
The Europe over the counter (OTC) drugs market size is calculated at USD 41.44 billion in 2025 and is predicted to attain around USD 74.56 billion by 2035, expanding at a CAGR of 6.05%.
August 2026
The India immunotherapy drugs market size accounted for USD 11.8 billion in 2025 and is predicted to touch around USD 73.67 billion by 2035, growing at a CAGR of 20.10%.
August 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
July 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
July 2026
The India asthma drugs market size was estimated at USD 2.16 billion in 2025 and is projected to be worth around USD 3.77 billion by 2035, growing at a CAGR of 5.72%.
July 2026
The global cancer diagnostics market size was exhibited at USD 170 billion in 2025 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
July 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The lyophilized injectable drugs market size was valued at USD 397.17 billion in 2025 and is expected to attain around USD 1,516.32 billion by 2035, with a CAGR of 14.34%.
July 2026
The asthma drugs market was valued at USD 26.49 billion in 2025 and is expected to hit around USD 42.74 billion by 2035, growing at a CAGR of 4.46% from 2026 to 2035.
July 2026
The global cardiovascular drugs market size is valued at USD 155.96 billion in 2025 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com